AHK-Cu
Copper-binding tripeptide cousin to GHK-Cu. Promoted specifically for hair-follicle support. Limited human data — most evidence is in vitro and topical formulation.
AHK-Cu is a hair-focused cousin to GHK-Cu. Same copper-binding family, different amino acid sequence, marketed for follicle support. Most evidence is in vitro and topical. Treat it like minoxidil's experimental sibling — slow, subtle, cumulative.
Naturally-occurring copper peptide derivative. Federations don't address it specifically.
Not FDA approved as a drug. Approved as a cosmetic ingredient in some formulations.
Not formally categorized in the FDA bulks lists.
Not prescribed in conventional medicine.
Who it's for
- →Users targeting hair-follicle support specifically
- →Stack add-on alongside GHK-Cu for skin + hair routines
- →Topical-only researchers
What to expect
- Week 1
Nothing visible yet.
- Week 4
Scalp irritation should fade if it appeared early.
- Week 8
Subtle follicle changes for responders. Most users see less than topical minoxidil produces.
How it works (mechanism)
Copper-binding tripeptide (alanine-histidine-lysine) similar to GHK-Cu in family but specialized for follicular activity. Activates dermal papilla cells in vitro.
Dosing protocol
Topical: 0.05-0.2% concentration, 1-2x daily. Sub-q: 1-2 mg daily, less commonly used.
Stacks well with
Side effects
When NOT to use
- ⚠Wilson's disease
- ⚠Active scalp infection
Common mistakes
- • Confusing it with GHK-Cu and using GHK-Cu protocols here
- • Storing in plastic (copper binds plastic — use glass)
- • Expecting fast follicle changes — visible response takes weeks
Educational only. User-specific dosing is between you and a qualified provider.